FDA clears bioMerieux's MRSA test

05/25/2011 | MedCityNews.com

The FDA has granted bioMerieux 510(k) clearance to market NucliSENS EasyQ MRSA, a molecular test that can spot seven types of methicillin-resistant Staphylococcus aureus. The test can process up to 46 samples and generate results in three hours.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Sr. Principal Electrical Engineer - 14000008LR
Abbott
San Jose, CA
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Systems Test - V&V Engineer - 14000008LS
Abbott
San Jose, CA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC